Chicago, IL, United States of America

John W Colson

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Clostrabio. Active years: 2026.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by John W. Colson

Introduction

John W. Colson is an accomplished inventor based in Chicago, IL (US). He has made significant contributions to the field of medical treatments, particularly in addressing infectious, autoimmune, and allergic diseases. His innovative work has led to the development of a patent that showcases his expertise and dedication to improving healthcare.

Latest Patents

John W. Colson holds a patent for "Methods and Compositions for Treating Infectious, Autoimmune, and Allergic Disease." This patent highlights his commitment to finding effective solutions for complex medical conditions. With 1 patent to his name, Colson's work is a testament to his innovative spirit and scientific acumen.

Career Highlights

Colson is currently associated with Clostrabio, a company focused on advancing biotechnological solutions. His role at Clostrabio allows him to collaborate with other talented professionals in the field. His career reflects a strong dedication to research and development, particularly in the realm of medical innovations.

Collaborations

Throughout his career, John W. Colson has worked alongside notable colleagues, including Lauren Anders Hesser and Dionysios Antonopoulos. These collaborations have enriched his work and contributed to the advancement of their shared goals in medical research.

Conclusion

John W. Colson's contributions to the field of medical treatment through his patent and work at Clostrabio exemplify the impact of innovation in healthcare. His dedication to addressing critical health issues continues to inspire advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…